124 related articles for article (PubMed ID: 26652134)
1. Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancer.
Drivalos A; Chrisofos M; Efstathiou E; Kapranou A; Kollaitis G; Koutlis G; Antoniou N; Karanastasis D; Dimopoulos MA; Bamias A
Urol Oncol; 2016 Apr; 34(4):165.e11-8. PubMed ID: 26652134
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between integrin subunits alpha5 and beta1 expressions in prostate cancer and its clinical implication].
Chen HJ; Wang H; Zhang L; Zhang YK; Wang GM
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):148-50. PubMed ID: 16519153
[TBL] [Abstract][Full Text] [Related]
3. Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.
Ren B; Yu YP; Tseng GC; Wu C; Chen K; Rao UN; Nelson J; Michalopoulos GK; Luo JH
J Natl Cancer Inst; 2007 Jun; 99(11):868-80. PubMed ID: 17551147
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of E-cadherin and N-cadherin in prostate cancer and their implications].
Liu Y; Chen XG; Liang CZ
Zhonghua Nan Ke Xue; 2014 Sep; 20(9):781-6. PubMed ID: 25306803
[TBL] [Abstract][Full Text] [Related]
5. [Relation of ME491/CD63 gene and integrin alpha5 in the invasion and metastases of ovarian cancer].
Xia ZJ; Zhang SL; Zhou Z
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):765-9. PubMed ID: 16324252
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of E-cadherin, N-cadherin, transforming growth factor-β1 and Twist in prostate cancer.
Liu GL; Yang HJ; Liu T; Lin YZ
Asian Pac J Trop Med; 2014 Jan; 7(1):76-82. PubMed ID: 24418088
[TBL] [Abstract][Full Text] [Related]
7. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.
Kolijn K; Verhoef EI; van Leenders GJ
Oncotarget; 2015 Sep; 6(27):24488-98. PubMed ID: 26041890
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of E-cadherin and alpha-catenin in benign, malignant and metastatic prostate tumors].
Jiang T; Jiang H; Su XM; Zheng L; Li QL; Zhang ZW; Li XC
Zhonghua Nan Ke Xue; 2012 Jun; 18(6):499-503. PubMed ID: 22774602
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
10. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
11. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
Sawada K; Mitra AK; Radjabi AR; Bhaskar V; Kistner EO; Tretiakova M; Jagadeeswaran S; Montag A; Becker A; Kenny HA; Peter ME; Ramakrishnan V; Yamada SD; Lengyel E
Cancer Res; 2008 Apr; 68(7):2329-39. PubMed ID: 18381440
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features.
Köksal IT; Ozcan F; Kiliçaslan I; Tefekli A
Pathology; 2002 Jun; 34(3):233-8. PubMed ID: 12109783
[TBL] [Abstract][Full Text] [Related]
13. [Correlation and significance of E-cadherin and N-cadherin expression in prostate cancer].
Huang X; Zhou LQ; Ai JK; Lu YQ; Bai Y; Zeng L; Zhang ZW; Guo YL
Ai Zheng; 2002 Nov; 21(11):1208-11. PubMed ID: 12526217
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.
Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X
Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of integrin alpha5, beta1 and E-CD in patients with non-small cell lung carcinoma].
Guo QS; Jia H; Han MY; Yu JM; Zhong WX
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):746-9. PubMed ID: 17366785
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.
Armstrong AJ; Healy P; Halabi S; Vollmer R; Lark A; Kemeny G; Ware K; Freedland SJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):40-5. PubMed ID: 26458958
[TBL] [Abstract][Full Text] [Related]
17. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
Nalla AK; Estes N; Patel J; Rao JS
Exp Cell Res; 2011 Oct; 317(17):2512-21. PubMed ID: 21855541
[TBL] [Abstract][Full Text] [Related]
18. Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology.
Soler AP; Harner GD; Knudsen KA; McBrearty FX; Grujic E; Salazar H; Han AC; Keshgegian AA
Am J Pathol; 1997 Aug; 151(2):471-8. PubMed ID: 9250159
[TBL] [Abstract][Full Text] [Related]
19. N-cadherin switching occurs in high Gleason grade prostate cancer.
Jaggi M; Nazemi T; Abrahams NA; Baker JJ; Galich A; Smith LM; Balaji KC
Prostate; 2006 Feb; 66(2):193-9. PubMed ID: 16173043
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer.
Musiał J; Sporny S; Nowicki A
Pol J Pathol; 2007; 58(4):235-43. PubMed ID: 18459457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
